GUY ROBERTS: Open Payments
NPI 1528085156 · FARMINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,001 in 170 payments from 31 companies in 2025. Trend: 2023 $3,192 · 2024 $2,864 · 2025 $3,001
Food & beverage: $2,912Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $509 |
| Otsuka America Pharmaceutical, Inc. | 13 | $252 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $192 |
| PFIZER INC. | 11 | $182 |
| Exact Sciences Corporation | 10 | $153 |
| Lilly USA, LLC | 7 | $145 |
| Axsome Therapeutics, Inc. | 8 | $138 |
| Vanda Pharmaceuticals Inc. | 8 | $137 |
| Novo Nordisk Inc | 11 | $137 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $114 |
Products named: REXULTI, CAPLYTA, VRAYLAR, UBRELVY, QULIPTA, MOUNJARO, FANAPT, XIFAXAN.
Industry payments across MO — which companies pay providers there.
